PAVmed Inc. Series Z Warrant
PAVMZ
PAVMZ was delisted on the 30th of April, 2025.
6 hedge funds and large institutions have $533K invested in PAVmed Inc. Series Z Warrant in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
28% less capital invested
Capital invested by funds: $737K → $533K (-$204K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
+$9.04K |
| 2 |
Morgan Stanley
New York
|
+$452 |
| 3 |
TWA
TCI Wealth Advisors
Tucson,
Arizona
|
+$452 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$364K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1.05K |
PAVMZ Hedge Fund Activity: Q4 2020 in Review
6 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q4 2020, worth a combined $533K — down 28% from $737K a quarter earlier.
Fund positioning in PAVMZ was balanced in Q4 2020: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Levin Capital Strategies, adding an estimated $9.04K. The largest seller was Sabby Management, exiting entirely with an estimated $364K sold.
- 6 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $533K of PAVmed Inc. Series Z Warrant stock for Q4 2020, down 28% quarter-over-quarter.
- 1 fund opened new PAVmed Inc. Series Z Warrant positions in Q4 2020 and 1 closed out, a net change of 0 holders.
- The largest PAVmed Inc. Series Z Warrant buyer in Q4 2020 was Levin Capital Strategies, an estimated $9.04K added.
- The largest PAVmed Inc. Series Z Warrant seller in Q4 2020 was Sabby Management, an estimated $364K sold.
Based on aggregated 13F filings for Q4 2020.